These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6889709)

  • 1. Lecithin administration in Alzheimer dementia.
    Dysken MW; Fovall P; Harris CM; Davis JM; Noronha A
    Neurology; 1982 Oct; 32(10):1203-4. PubMed ID: 6889709
    [No Abstract]   [Full Text] [Related]  

  • 2. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).
    Brinkman SD; Pomara N; Goodnick PJ; Barnett N; Domino EF
    J Clin Psychopharmacol; 1982 Aug; 2(4):281-5. PubMed ID: 7119136
    [No Abstract]   [Full Text] [Related]  

  • 3. Early results from double-blind, placebo controlled trial of high dose phosphatidylcholine in Alzheimer's disease.
    Levy R; Little A; Chuaqui P; Reith M
    Lancet; 1983 Apr; 1(8331):987-8. PubMed ID: 6132292
    [No Abstract]   [Full Text] [Related]  

  • 4. Double blind study of lecithin in patients with Alzheimer's disease.
    Fisman M; Merskey H; Helmes E; McCready J; Colhoun EH; Rylett BJ
    Can J Psychiatry; 1981 Oct; 26(6):426-8. PubMed ID: 7028239
    [No Abstract]   [Full Text] [Related]  

  • 5. Lecithin in Alzheimer's disease.
    Etienne P; Gauthier S; Dastoor D; Collier B; Ratner J
    Lancet; 1978 Dec; 2(8101):1206. PubMed ID: 82173
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of physostigmine and lecithin on memory in Alzheimer disease.
    Peters BH; Levin HS
    Ann Neurol; 1979 Sep; 6(3):219-21. PubMed ID: 534419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer disease: lack of effect of lecithin treatment for 3 months.
    Etienne P; Dastoor D; Gauthier S; Ludwick R; Collier B
    Neurology; 1981 Dec; 31(12):1552-4. PubMed ID: 7198209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
    Wettstein A
    Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lecithin in the treatment of Alzheimer's disease.
    Weintraub S; Mesulam MM; Auty R; Baratz R; Cholakos BN; Kapust L; Ransil B; Tellers JG; Albert MS; LoCastro S; Moss M
    Arch Neurol; 1983 Aug; 40(8):527-8. PubMed ID: 6347143
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral physostigmine and lecithin improve memory in Alzheimer disease.
    Thal LJ; Fuld PA; Masur DM; Sharpless NS
    Ann Neurol; 1983 May; 13(5):491-6. PubMed ID: 6347034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease.
    Pomara N; Domino EF; Yoon H; Brinkman S; Tamminga CA; Gershon S
    J Clin Psychiatry; 1983 Aug; 44(8):293-5. PubMed ID: 6874650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lecithin does not affect EEG spectral analysis or P300 in Alzheimer disease.
    Canter NL; Hallett M; Growdon JH
    Neurology; 1982 Nov; 32(11):1260-6. PubMed ID: 6890160
    [No Abstract]   [Full Text] [Related]  

  • 13. Memory enhancement with oral physostigmine in Alzheimer's disease.
    N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluctuations of free choline levels in plasma of Alzheimer patients receiving lecithin: preliminary observations.
    Chuaqui P; Levy R
    Br J Psychiatry; 1982 May; 140():464-9. PubMed ID: 7049290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of cholesterol risk factors by lecithin in patients with Alzheimer's disease.
    Vroulis G; Smith RC; Schoolar JC; Dahlen G; Katz E; Misra CH
    Am J Psychiatry; 1982 Dec; 139(12):1633-4. PubMed ID: 7149071
    [No Abstract]   [Full Text] [Related]  

  • 16. Lecithin in Alzheimer's disease.
    Levy R
    Lancet; 1982 Sep; 2(8299):671-2. PubMed ID: 6125806
    [No Abstract]   [Full Text] [Related]  

  • 17. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of lecithin on memory in patients with senile dementia of the Alzheimer's type [proceedings].
    Vroulis GA; Smith RC; Brinkman S; Schoolar J; Gordon J
    Psychopharmacol Bull; 1981 Jan; 17(1):127-8. PubMed ID: 7232644
    [No Abstract]   [Full Text] [Related]  

  • 19. Lecithin and memory training in suspected Alzheimer's disease.
    Brinkman SD; Smith RC; Meyer JS; Vroulis G; Shaw T; Gordon JR; Allen RH
    J Gerontol; 1982 Jan; 37(1):4-9. PubMed ID: 7031118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
    Little A; Levy R; Chuaqui-Kidd P; Hand D
    J Neurol Neurosurg Psychiatry; 1985 Aug; 48(8):736-42. PubMed ID: 3897460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.